Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, August 25-27
August 23, 2021 16:00 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of...
PROCESSA PHARMACEUTICALS PROVIDES SHAREHOLDER UPDATE
February 25, 2020 09:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing drugs to improve the survival and/or quality of...